These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18363420

  • 1. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
    Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS.
    J Clin Psychiatry; 2008 Apr; 69(4):659-65. PubMed ID: 18363420
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of controlled-release paroxetine in the treatment of late-life depression.
    Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.
    J Clin Psychiatry; 2003 Sep; 64(9):1065-74. PubMed ID: 14628982
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
    Lanza di Scalea T, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study.
    Asnis GM, Bose A, Gommoll CP, Chen C, Greenberg WM.
    J Clin Psychiatry; 2013 Mar; 74(3):242-8. PubMed ID: 23561229
    [Abstract] [Full Text] [Related]

  • 15. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [Abstract] [Full Text] [Related]

  • 16. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
    Kasper S, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2005 Aug; 21(8):1139-46. PubMed ID: 16083521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A, Roose S.
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.